BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, December 31, 2025
See today's BioWorld Asia
Home
» Other news to note for May 25, 2021
To read the full story,
subscribe
or
sign in
.
Other news to note for May 25, 2021
May 25, 2021
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Amerimmune, Apex Services Pakistan, Astrazeneca UK, Bioarc, Biontech, Bioray, Celltrion, Clover, Dr. Reddy’s, Eisai, Ethypharm, Eurocine Vaccines, Eurofins Discovery, Histogen, Immunome, Immunoprecise Antibodies, Imugene, Moderna, Mountain Valley MD, Nascent, Novavax, Organicell Regenerative Medicine, Oxford Biomedica, Pfizer, Postera, Prestige, Pulthera, Recce, Replicel Life Sciences, Resverlogix, Samsung Biologics, Santé Laboratories, Shenzhen Hepalink, SK Group, Sosei, Stemedica Cell Technologies, Synairgen, Therapeutic Solutions International.
BioWorld Asia
Briefs
Other news to note